New Discovery: CBD Inhibits Hepatitis Virus
In a research paper published in the recent edition of the highly respected Pharmacognosy Research Journal, Dr. Lowe – an adjunct Professor at the University of Maryland School of Medicine (UMSOM), concludes that CBD (extracted from marijuana and hemp) demonstrates significant antiviral properties against the Hepatitis C Virus in vitro, and Hepatitis B in vivo.
A cost-effective treatment for the more than 3 million Americans who suffer from the hepatitis C virus (HCV) may now be on the horizon. Researchers have discovered that the phytochemical CBD inhibits HCV. HCV is the leading cause of liver cancer, an aggressive cancer with a high mortality rate that will kill more than 20,000 in the U.S. this year alone.
Most studies on CBD focus on the powerful anti-inflammatory, neuroprotective, and antioxidant properties of the phytocannabinoid cannabidiol (CBD). As a result, little has been researched regarding the anti-viral activity of CBD. That is, until now.
Click Here for the rest of the article.
Remember - As a CBD consultant you never want to make any medical claims. You can provide your customers with information on the research being done, but be careful not to state that CBD will cure anything.
Now is the time to be a leader in the CBD industry. Get Certified!